StockMarketWire.com - Antibiotics developer Motif Bio noted that Amphion Innovations had sold some of its holding in the company to an institutional investor.

Amphion now held 8.51% of the issued share capital of Motif Bio, the company said.

According to Amphion's filing, it had previously held a 9.53% in Motif Bio.



At 9:04am:

[LON:AMP] Amphion Innovations PLC share price was 0p at 0.8p

[LON:MTFB] Motif Bio Plc Ord 1p share price was -0.67p at 34.18p



Story provided by StockMarketWire.com